Under such circumstances, the insult's sufficient to damage the foal, but insufficient to cause clear-cut symptoms in the mare".
As new drugs to treat and even prevent Alzheimer's disease make their way through the pipeline, a basic medical issue has remained unresolved: how can doctors know which patients to medicate if they are not yet showing clear-cut symptoms?
In this population, primarily of northern European descent, more than 400 patients, or nearly 25percentt who visited a primary care doctor for any reason, had clear-cut symptoms of restless legs syndrome, a prevalence twice that observed in previous studies.
The lack of clear-cut symptoms in most patients with even profoundly reduced levels of plasma (P -Mg has left it uncertain whether Mg substitution should be instituted when the value is low.
Resistance to treatment was suggested by previous studies, as an important factor in the success of the lifestyle modifications and in the achievement of desired outcomes [ 14, 15], mainly in patients with no clear-cut symptoms, as is the case in most patients diagnosed with diabetes.
The observation that these cancers are associated with long patient intervals despite the presence of clear-cut symptoms in most patients subsequently diagnosed with them would, in principle, advocate the development and evaluation of public health campaigns aimed at raising awareness of symptoms, and appropriate help-seeking behaviour, for these (rarer) cancers.
Bearing this observation in mind it is apparent that, where present, cancer-specific inequalities (by sex, deprivation and age) tend to relate to cancers characterised by clear-cut symptoms in most patients (i.e., oral/oropharygeal cancer – oral ulceration/lesion; melanoma – visible skin lesion; anal – anal ulceration/lesions; and laryngeal – voice hoarseness).
Finally, there is a group of cancers for which men are at greater risk of diagnosis through an emergency presentation – for example, oral and oropharyngeal cancer (both characterised by clear-cut symptoms (oral ulceration/lesion) in most patients) and melanoma (visible skin lesions in most patients)).
First, most known sociodemographic inequalities in markers of diagnostic timeliness (such as stage at diagnosis) are concentrated on cancers with relatively clear-cut symptom signatures that is cancers in which the majority of patients present with visible, palpable or audible symptoms (Lyratzopoulos and Abel, 2013; Lyratzopoulos et al, 2013a; Robbins et al, 2014).
The pricey drug cut flu symptoms like fever and body aches by less than a day when compared to a placebo.
